Narnatumab

Narnatumab
Monoclonal antibody
Type Whole antibody
Source Mouse
Target CD22
Clinical data
ATC code none
Identifiers
CAS Number 1188275-92-4 N
ChemSpider none
Chemical and physical data
Formula C6454H10026N1754O2020S44
Molar mass 145.9 kg/mol
 NYesY (what is this?)  (verify)

Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1]

Narnatumab was developed by ImClone Systems.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab" (PDF). American Medical Association.


This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.